UHS will offer the Johnson & Johnson COVID-19 vaccine at the Kohl Center (Gate C) on Friday, June 25 and Monday, June 28. Clinic times are 9 am – noon, and 1 – 4 p.m.
No appointment is needed.
The Johnson & Johnson vaccine is administered in one dose. While some people will not have any side effects from the vaccine, others may experience symptoms such as headache and mild fever.
On April 13, 2021, use of the Johnson & Johnson vaccine was briefly paused after national vaccine safety monitoring found that a very small number of people — all women between 18 and 49 years old — out of millions who had received the vaccine developed rare blood clots and low platelets.
A sign that the safety mechanisms in place to detect adverse events was working properly, the pause gave the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration opportunity to further review available data and conduct extensive outreach to health care providers. This helps ensure they’re aware of the potential for this syndrome and able to provide appropriate management and treatment.
On April 23, 2021, the brief pause was lifted after a thorough safety review determined the vaccine is safe and effective in preventing COVID-19. Medical and scientific experts determined that the chance of this syndrome occurring is very low. For women between ages 18 and 49, about 7 in one million may experience the condition.
If you receive the Johnson & Johnson vaccine, contact your health care provider immediately if you experience any of the following symptoms within three weeks of receiving your vaccine: shortness of breath, chest pain, leg swelling, persistent abdominal pain, severe or persistent headaches, blurred vision, easy bruising or tiny spots under the skin beyond their injection site.